Grail Inc (GRAL)

Apr 22, 2025, 4:01 PM EDT - 4 days ago

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

Apr 21, 2025, 4:47 PM EDT - 5 days ago

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

Apr 12, 2025, 9:32 AM EDT - 14 days ago

GRAIL's Galleri Progresses While Back In Accumulation Levels

Apr 8, 2025, 9:49 AM EDT - 18 days ago

How Does GRAIL Benefit From The Proposed MCED Legislation?

Feb 26, 2025, 4:05 PM EST - 2 months ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 25, 2025, 9:00 AM EST - 2 months ago

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

Feb 21, 2025, 9:00 AM EST - 2 months ago

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Feb 20, 2025, 10:09 PM EST - 2 months ago

GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:02 PM EST - 2 months ago

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 12, 2025, 4:02 PM EST - 2 months ago

GRAIL to Announce Fourth Quarter 2024 Financial Results

Feb 12, 2025, 9:00 AM EST - 2 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

DGX

Jan 27, 2025, 12:05 AM EST - 3 months ago

Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week

Jan 22, 2025, 1:01 PM EST - 3 months ago

Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%

Jan 13, 2025, 6:49 PM EST - 3 months ago

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

Dec 18, 2024, 4:01 PM EST - 4 months ago

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 5, 2024, 5:46 AM EST - 5 months ago

World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles

Nov 19, 2024, 4:05 PM EST - 5 months ago

GRAIL to Participate in Upcoming Investor Conferences

Nov 18, 2024, 4:01 PM EST - 5 months ago

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

AZN

Nov 15, 2024, 4:18 AM EST - 5 months ago

GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:06 PM EST - 5 months ago

GRAIL Reports Third Quarter 2024 Financial Results

Nov 4, 2024, 4:01 PM EST - 6 months ago

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Oct 29, 2024, 4:01 PM EDT - 6 months ago

GRAIL to Announce Third Quarter 2024 Financial Results

Oct 23, 2024, 6:00 PM EDT - 6 months ago

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

Oct 21, 2024, 4:01 PM EDT - 6 months ago

GRAIL Appoints Sarah Krevans to Board of Directors

Oct 4, 2024, 8:00 AM EDT - 7 months ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Oct 3, 2024, 12:30 PM EDT - 7 months ago

Vieu cracks the “holy grail” of B2B sales with AI-powered business network; raises $11m as growth scales

Sep 24, 2024, 12:41 PM EDT - 7 months ago

GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success

ILMN

Sep 9, 2024, 9:16 AM EDT - 8 months ago

GRAIL's Potential Turnaround: Seeking FDA Approval For Galleri

Sep 3, 2024, 3:50 AM EDT - 8 months ago

EU top court backs Illumina fight against EU probe into Grail deal

ILMN

Aug 30, 2024, 5:55 PM EDT - 8 months ago

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

Aug 29, 2024, 4:16 PM EDT - 8 months ago

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

ILMN

Aug 21, 2024, 4:01 PM EDT - 8 months ago

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 13, 2024, 8:44 PM EDT - 9 months ago

GRAIL Inc. (GRAL) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:13 PM EDT - 9 months ago

Grail to cut jobs, planned hires for 2024 by about 30%

Aug 13, 2024, 4:01 PM EDT - 9 months ago

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

Jul 31, 2024, 4:05 PM EDT - 9 months ago

GRAIL to Announce Second Quarter 2024 Financial Results

Jul 18, 2024, 9:00 AM EDT - 10 months ago

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

Jul 15, 2024, 3:01 AM EDT - 10 months ago

GRAIL Advances the Galleri® Registrational Clinical Trial Program

Jun 28, 2024, 2:30 PM EDT - 10 months ago

Undercovered Dozen: Telus Corporation, X-FAB Silicon Foundries, GRAIL, And More

TU

Jun 28, 2024, 4:35 AM EDT - 10 months ago

Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out

ILMN

Jun 27, 2024, 5:26 PM EDT - 10 months ago

Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2

ILMN

Jun 26, 2024, 2:18 PM EDT - 10 months ago

Illumina Completes Spin-Off Of GRAIL

ILMN

Jun 26, 2024, 9:02 AM EDT - 10 months ago

GRAIL: Ambitious Illumina Spin-Off Trading At Intriguing Valuation

ILMN

Jun 25, 2024, 9:41 AM EDT - 10 months ago

Grail's shares fall in Nasdaq debut after spin-off from Illumina

Jun 25, 2024, 9:09 AM EDT - 10 months ago

Grail expected to be first FDA-approved multi-cancer test, says CEO Bob Ragusa

Jun 24, 2024, 4:50 PM EDT - 10 months ago

Grail bets big on flagship cancer test after spin-off from Illumina

ILMN

Jun 24, 2024, 4:05 PM EDT - 10 months ago

GRAIL to Begin Trading on the Nasdaq Stock Exchange